Form 4: Surgery Partners Director Acquires Shares

Laura L. Forese, a Director at Surgery Partners, Inc., acquired 11,670 shares of common stock on June 5, 2026, with vesting scheduled for June 5, 2027.

Summary

• Laura L. Forese, a Director of Surgery Partners, Inc. (SGRY), acquired 11,670 shares of common stock on June 5, 2026.
• The acquisition was made at a price of $13.71 per share.
• These shares are subject to vesting on June 5, 2027.
• Following this transaction, Ms. Forese beneficially owns 18,531 shares of common stock.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing due to the director's acquisition of shares, which can signal confidence, but it does not provide operational or financial performance updates.

Positives

• Director acquisition of company stock can signal confidence in the company's future prospects.
• The acquisition of 11,670 shares represents a notable investment by a key insider.

Future Outlook

The filing does not contain forward-looking statements or guidance. The primary information relates to a past transaction and future vesting of shares.

Industry Context

StockSavvy.ai notes that insider stock acquisitions, particularly by directors, are often viewed positively by the market as they can indicate management's belief in the company's intrinsic value and future growth potential within the healthcare services sector.

Stakeholder Impact

• Shareholders may view the director's stock purchase as a positive signal of confidence in the company's future performance.
• Employees may interpret this as a sign of strong leadership commitment.

Next Steps

• The acquired shares will vest on June 5, 2027.

Key Dates

Keywords

Surgery Partners, SGRY, Form 4, Insider Trading, Director, Stock Acquisition, Beneficial Ownership, Vesting